Strain differences in the behavioral responses of male rats to chronically administered methylphenidate

Brain Research

Volumn 971, Issue 2, 2003, Pages 139-152

  Yang, Pamela B ^a   Amini, Behrang ^a   Swann, Alan C ^a   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Behavioral sensitization; Locomotor activity; Methylphenidate (Ritalin); Spontaneously hypertensive rat (SHR); Sprague Dawley; Wistar Kyoto

Indexed keywords

METHYLPHENIDATE; SODIUM CHLORIDE;

ARTICLE; AUTOMATION; BEHAVIOR; BIOLOGICAL MONITORING; CONTROLLED STUDY; GENETIC VARIABILITY; HYPERTENSION; LOCOMOTION; MALE; MEDICAL RECORD; MOVEMENT (PHYSIOLOGY); MUSCULOSKELETAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STRAIN DIFFERENCE;

EID: 0037427382     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04240-3     Document Type: Article

References (69)

1. Accardo P., Blondis T.A. What's all the fuss about Ritalin? J. Pediatr. 138:2001;6-9.
2. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 25:2001;651-661.
3. Cailhol S., Mormede P. Strain and sex differences in the locomotor response and behavioral sensitization to cocaine in hyperactive rats. Brain Res. 842:1999;200-205.
4. Crawford C.A., McDougall S.A., Meier T.L., Collins R.L., Watson J.B. Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology. 136:1998;24-33.
5. Delf J.M., Schreiber L., Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci. 10:1990;303-310.
6. Drug Enforcement Administration, Office of Diversion Control. Methylphenidate Review: Eight Factor Analysis. 2000;Drug Enforcement Administration, Washington, DC.
7. Eichlseder W. Ten years of experience with 1000 hyperactive children in a private practice. Pediatrics. 76:1985;176-181.
8. Elmer G.I., Gorelick D.A., Goldberg S.R., Rothman R.B. Acute sensitivity versus context-specific sensitization to cocaine as a function of genotype. Pharmacol. Biochem. Behav. 53:1996;623-628.
9. Fessler R.G., Sturgeon R.D., Meltzer H.F. Effects of phencyclidine and methylphenidate on D-amphetamine-induced behavior in reserpine pretreated rats. Pharmacol. Biochem. Behav. 13:1980;835-842.
10. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res. Rev. 26:1998;148-153.
11. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., Logan J. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology. 146:1999;93-100.
12. Gaytan O., al-Rahim S., Swann A., Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 61:1997;PL101-PL107.
13. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 777:1997;1-12.
14. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res. 864:2000;24-39.
15. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P., Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J. Pharmacol. Exp. Ther. 295:2000;51-57.
16. Gessa G.L., Pani L., Serra G., Fratta W. Animal models of mania. Adv. Biochem. Psychopharmacol. 49:1995;43-66.
17. Goldman L.S., Genel M., Bezman R.J., Slanetz P.J. Diagnosis and treatment of attention deficit/hyperactivity disorder in children and adolescents. J. Am. Med. Assoc. 279:1998;1100-1107.
18. Grollman A. The spontaneously hypertensive rat: an experimental analogue of essential hypertension in the human being. Okamoto K. Spontaneous Hypertension: Its Pathogenesis and Complications. 1972;238-242 Igaku Shoin, Tokyo.
19. Harris H.W., Nestler E.J. Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats. Brain Res. 706:1996;1-12.
20. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Individual differences in locomotor activity and sensitization. Pharmacol. Biochem. Behav. 38:1991;467-470.
21. Izenwasser S., Coy A.E., Ladenheim B., Loeloff R.J., Cadet J.L., Dawn F. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur. J. Pharmacol. 373:1999;187-193.
22. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
23. Kalivas P.W. Neural basis of behavioral sensitization to cocaine. Hammer R.P. The Neurobiology of Cocaine. 1995;81-98 CRC Press, Boca Raton, FL.
24. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role of sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12:1998;49-53.
25. Karler R., Chaudhry I.A., Calder L.D., Turkanis S.A. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:1990;76-82.
26. Karler R., Calder L.D., Bedingfield J.B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115:1994;305-310.
27. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
28. King J.A., Kelly T.A., Deville Y. Adult levels of testosterone alter catecholamine innervation in an animal model of attention deficit hyperactivity disorder. Neuropsychobiology. 42:2000;163-168.
29. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in non-human and human subjects. A review. Pharmacol. Biochem. Behav. 68:2001;611-627.
30. Kuczenski R., Segal D.S. Sensitization of amphetamine-induced stereotyped behaviors during the acute response. J. Pharmacol. Exp. Ther. 288:1999;699-709.
31. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296:2001;876-883.
32. Liebermann J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 17:1997;205-229.
33. McCarty R., Kopin I.J. Patterns of behavioral development in spontaneously hypertensive rats and Wistar-Kyoto normotensive controls. Dev. Psychobiol. 12:1979;239-243.
34. McCarty R., Chiueh C.C., Kopin I.R. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to D-amphetamine. Pharmacol. Biochem. Behav. 12:1979;53-59.
35. Myers M.M., McCrory D., Bulman C.A., Hendley E.D. Open field behavior and brain norepinephrine uptake in spontaneously hypertensive rats and Wistar-Kyoto normotensive controls. Fed. Proc. 36:1977;1047.
36. Newcorn J.H. A glimpse into key issues in ADHD. CNS Spectrum. 5:2000;25.
37. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27:1963;282-293.
38. Pauls D.L. Genetic factors in the expression of attention-deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 1:1991;353-360.
39. Pelham W.E., Gnagy E.M., Burrows-Maclean L., Williams A., Fabiano G.A., Morrisey S.M., Chronis A.M., Forehand G.L., Nguyen C.A., Hoffman M.T., Lock T.M., Fiebelkorn K., Coles E.K., Panahon C.J., Steiner R.L., Meichenbaum D.L., Onyango A.N., Morse G.D. Once-a-day concerta methylphenidate versus three times-daily methylphenidate in laboratory and natural settings. Pediatrics. 107:2001;1-15.
40. Phillips T.J. Behavior genetics of drug sensitization. Crit. Rev. Neurobiol. 11:1997;21-33.
41. Pierce C.R., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
42. Post R.M., Weiss S.R., Pert A. Cocaine-induced behavioral sensitization and kindling: implications for the emergence of psychopathology and seizures. Ann. NY Acad. Sci. 537:1988;292-308.
43. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
44. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine psychosis. Brain Res. 396:1986;157-198.
45. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. 18:1993;247-291.
46. Russell V.A., Villiers A.S., Sagvolden T., Lamm M.L., Taljaard J.F. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. Bull. 53:2000;187-192.
47. Ruth J.A., Ullman E.A., Collins A.C. An analysis of cocaine effects on locomotor activities and heart rate in four inbred mouse strains. Pharmacol. Biochem. Behav. 29:1988;157-162.
48. Safer D.J., Zito J.M., Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 98:1996;1084-1088.
49. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev. 24:2000;31-39.
50. Sagvolden T., Sergeant J.A. Attention deficit/hyperactivity disorder - from brain dysfunctions to behavior. Behav. Brain Res. 94:1998;1-10.
51. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 58:1992;103-112.
52. Santosh P.J., Taylor E. Stimulant drugs. Eur. Child Adolesc. Psychiatry. 9:2000;1-28.
53. Sax K.W., Strakowski S.M. Enhanced behavioral response to repeated D-amphetamine and personality traits in humans. Biol. Psychiatry. 44:1998;1192-1195.
54. Scheel-Kruger J. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur. J. Pharmacol. 14:1971;47-59.
55. Segal D.S., Mandell A.J. Long-term administration of D-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2:1974;249-255.
56. Segal D.S., Kuczenski R. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242:1987;917-926.
57. Shuster L., Yu G., Bates A. Sensitization to cocaine stimulation in mice. Psychopharmacology. 52:1977;185-190.
58. Shuster L., Hudson J., Anton M., Righi D. Sensitization of mice to methylphenidate. Psychopharmacology. 77:1982;31-36.
59. Solanto M.V. Clinical psychopharmacology of ADHD: implications for animal models. Neurosci. Biobehav. Rev. 24:2000;27-30.
60. Swanson J., Gupta S., Guinta D., Flynn D., Agler D., Lerner M., Williams L., Shoulson I., Wigal S. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin. Pharmacol. Ther. 66:1999;295-305.
61. Tilson H.A., Chamberlain J.H., Gylys J.A., Buyniski J.P. Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats. Eur. J. Pharmacol. 43:1977;99-105.
62. Tolliver B.K., Belknap J.K., Woods W.E., Carney J.M. Genetic analysis of sensitization and tolerance to cocaine. J. Pharmacol. Exp. Ther. 270:1994;1230-1238.
63. Venter A. Methylphenidate (Ritalin): old truths and new facts. Pedmed. 9:1996;15-21.
64. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y.S. Ding, S.J. Gatley, A. Gifford, D. Franceschi, Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain, J. Neurosci. 21 (2001) RC121: 1-5.
65. White S.R., Yadao C.M. Characterization of methylphenidate exposures reported to a regional poison control center. Arch. Pediatr. Adolesc. Med. 154:2000;1199-1203.
66. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
67. Wultz B., Sagvolden T., Moser E.I., Moser M.B. The spontaneously hypertensive rat as an animal model of ADHD: effects of methylphenidate on exploratory behavior. Behav. Neural Biol. 26:1990;676-686.
68. Yang P., Beasley A., Swann A., Dafny N. Valproate modulates the expression of methylphenidate (Ritalin) sensitization. Brain Res. 874:2000;216-220.
69. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. Am. Med. Assoc. 283:2000;1025-1030.